Study of DNP002 in Patients With Solid Tumors

NCT06466265 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: DNP002

Sponsor

Kumho HT Inc.